Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study-Reference-Cited by-同舟云学术

Slower Recovery with Early Lopinavir/Ritonavir use in Pediatric COVID-19 Patients: A Retrospective Observational Study

Published:2022-04-16 Issue:3 Volume:24 Page:269-280
ISSN:1174-5878
Container-title:Pediatric Drugs
language:en
Short-container-title:Pediatr Drugs

Author:

Wong Carlos K. H.^ORCID,Low Marshall C. H.,Kwok Ashley C. Y.,Lui Angel Y. C.,Lau Kristy T. K.^ORCID,Au Ivan C. H.^ORCID,Xiong Xi^ORCID,Chung Matthew S. H.^ORCID,Kwan Mike Y. W.^ORCID,Lau Eric H. Y.^ORCID,Cowling Benjamin J.^ORCID

Funder

Health and Medical Research Fund

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pediatrics, Perinatology and Child Health

Link

https://link.springer.com/content/pdf/10.1007/s40272-022-00500-7.pdf

Reference56 articles.

1. World Health Organisation. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/. Accessed 23 Feb 2022.

2. Ludvigsson JF. Systematic review of COVID-19 in children shows milder cases and a better prognosis than adults. Acta Paediatr. 2020;109(6):1088–95.

3. Rubens JH, Akindele NP, Tschudy MM, Sick-Samuels AC. Acute covid-19 and multisystem inflammatory syndrome in children. Bmj. 2021;372

4. Chua GT, Wong JSC, Lam I, et al. Clinical characteristics and transmission of COVID-19 in children and youths during 3 waves of outbreaks in Hong Kong. JAMA Netw Open. 2021;4(5):e218824–e218824.

5. Venturini E, Montagnani C, Garazzino S, et al. Treatment of children with COVID-19: position paper of the Italian Society of Pediatric Infectious Disease. Ital J Pediatr. 2020;46(1):1–11.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drugs for COVID-19: An Update;Molecules;2022-12-05

2. Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone;Frontiers in Pharmacology;2022-05-30

3. Lopinavir/ritonavir delays COVID-19 recovery in paediatric patients;Reactions Weekly;2022-04